1-4 of 4
Steven A. Buck
Close
Sort by
Journal Articles

Targeting The Wee1 Kinase With MK-1775 For Treatment Of Acute Myeloid Leukemia In The Down Syndrome Population

J. Timothy Caldwell, Steven A Buck, Yubin Ge, PhD, Jeffrey W Taub, MD
Journal: Blood
Blood (2013) 122 (21): 3836.
https://doi.org/10.1182/blood.V122.21.3836.3836
Published: 2013
Journal Articles

RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia

Holly Edwards, Chengzhi Xie, Katherine M. LaFiura, Alan A. Dombkowski, Steven A. Buck, Julie L. Boerner, Jeffrey W. Taub, Larry H. Matherly, Yubin Ge
Journal: Blood
Blood (2009) 114 (13): 2744–2752.
https://doi.org/10.1182/blood-2008-09-179812
Published: 2009
Includes: Supplemental data
Journal Articles

Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia

Clinical Trials & Observations
Yubin Ge, Alan A. Dombkowski, Katherine M. LaFiura, Dana Tatman, Ravikiran S. Yedidi, Mark L. Stout, Steven A. Buck, Gita Massey, David L. Becton, Howard J. Weinstein, Yaddanapudi Ravindranath, Larry H. Matherly, Jeffrey W. Taub
Journal: Blood
Blood (2006) 107 (4): 1570–1581.
https://doi.org/10.1182/blood-2005-06-2219
Published: 2006
Journal Articles

Expression of Chromosome 21-Localized Genes in Acute Myeloid Leukemia: Differences Between Down Syndrome and Non-Down Syndrome Blast Cells and Relationship to In Vitro Sensitivity to Cytosine Arabinoside and Daunorubicin

Jeffrey W. Taub, Xi Huang, Larry H. Matherly, Mark L. Stout, Steven A. Buck, Gita V. Massey, David L. Becton, Myron N. Chang, Howard J. Weinstein, Yaddanapudi Ravindranath
Journal: Blood
Blood (1999) 94 (4): 1393–1400.
https://doi.org/10.1182/blood.V94.4.1393
Published: 1999